T1 Energy (TE) Q2 2026 earnings review
G2 Cost Blowout and Profitability Reversal Overshadow Volume Gains
T1 Energy's Q2 preliminary results completely contradict the 'shift to profitability' narrative established in Q1. While module sales volume accelerated sequentially to 835 MW driving ~$250M in revenue, Adjusted EBITDA reversed back to a $13M loss. The most alarming updates stem from the flagship G2_Austin fab: capital expenditure estimates spiked 20% to $510M due to tight Texas labor markets, and the start of production was delayed to Q1 2027. With comprehensive financing still unsigned, cash burn is a critical risk.
🐂 Bull Case
The company successfully sold its remaining 2025 Section 45X tax credits at a gross price of $0.93 on the dollar, generating $39.1M. This is an accelerating pricing trend compared to the $0.91 achieved in late 2025.
Management expects 2026 production to fall within the higher end of the 3.1 - 4.2 GW range, driven by successful qualification of international cell vendors and an accelerating run rate expected in H2.
🐻 Bear Case
G2_Austin Phase 1 CapEx guidance surged 20% from $425M to $510M due to labor tightness in the Texas data center market. The target for first cell production slipped from year-end 2026 to Q1 2027.
Despite a sequential revenue increase of ~40% vs Q1, Adjusted EBITDA flipped from +$9.1M back to a loss of ~$13.0M. The operational leverage touted in Q1 did not hold.
⚖️ Verdict: 🔴
Bearish. The core bullish thesis for T1 rests on the timely and cost-effective execution of the G2_Austin fab to capture integrated margins. A 20% CapEx blowout, a quarter-long delay, an unclosed financing package, and returning to negative EBITDA collectively form a severe crack in the investment narrative.
Key Themes
G2_Austin CapEx Blowout & Delay
The centerpiece of T1's strategy, the G2_Austin fab, is facing significant execution headwinds. Management revised Phase 1 CapEx up by 20% to $510M (previously $425M). The culprit is a macroeconomic factor: labor and materials cost tightness driven by the booming Texas data center construction market. Consequently, the first cell production timeline has been delayed from year-end 2026 to Q1 2027.
Profitability Reversing Course
In Q1, management celebrated a 'shift to profitability' with record Adjusted EBITDA of $9.1M on 683 MW of throughput. However, this narrative abruptly contradicted itself in Q2. Despite throughput accelerating to 835 MW and revenue growing sequentially to ~$250M, Adjusted EBITDA reversed to a midpoint loss of $13M. This suggests severe gross margin compression or unconstrained operating expenses.
Financing Gap & Liquidity Drain
The comprehensive financing solution for G2_Austin remains an overhang. While T1 ended Q2 with $156.4M in total cash, only $79.1M was unrestricted. Alarmingly, management just announced a $135M acquisition of Evervolt IP rights. While this bolsters technology, executing a massive cash acquisition while facing a $510M CapEx bill and relying on unfinalized debt financing severely elevates liquidity risk.
Section 45X Credit Monetization Premium
A bright spot for cash flow: T1 successfully monetized its remaining 2025 Section 45X tax credits for $39.1M. Crucially, the gross price realized was $0.93 on the dollar. This is an accelerating rate compared to the $0.91 achieved in late 2025, validating the high market demand for these credits.
G1 Production Running at High End
Module sales volume is accelerating. Management expects the run rate in Q3 and Q4 to exceed Q2's 835 MW. Due to progress in qualifying international cell vendors for the Dallas facility, full-year production is now expected to fall within the higher end of the 3.1 - 4.2 GW guidance range.
Tariff Recovery Inbound
T1 expects to realize approximately $24.4 million of refunds for tariffs incurred under the International Emergency Economic Powers Act (IEEPA) in Q2. While excluded from Adjusted EBITDA, this is a significant injection of non-dilutive capital that will temporarily support the balance sheet.
Other KPIs
Decelerating. Down from $182.4 million in Q1. While total cash including restricted funds sits at $156.4M, the thin layer of unrestricted cash underscores the urgency to close the G2 financing package, especially with G2 CapEx estimates rising to $510M.
Reversing. Flipped back into deep negative territory compared to a positive $3.9M in Q1 2026. Highlights that the operational efficiency and favorable contract mix touted in Q1 did not translate to Q2.
Guidance
Accelerating cost profile. Management added a 20% contingency to the previous $425 million estimate. They directly cite labor and materials costs associated with tightness in the Texas data center construction market. This significantly increases the required size of the pending debt package.
Stable to Accelerating. Maintained the range but confidently pointed to the upper bound. Run rates in H2 are explicitly guided to exceed the Q2 output, supported by newly qualified international cell vendors.
Key Questions
Margin Compression Bridge
Revenue and MW volumes grew sequentially from Q1 to Q2, yet Adjusted EBITDA fell from +$9 million to -$13 million. What exactly drove this severe negative operating leverage, and was Q1 an anomaly rather than a 'shift to profitability'?
Liquidity and the Evervolt IP Purchase
You ended Q2 with $79.1M in unrestricted cash, face a revised $510M G2 CapEx bill, and the financing package isn't closed. In this context, how is the $135M Evervolt IP acquisition being funded, and does this threaten G2 execution?
Impact of G2 Delay on 2027 EBITDA Targets
With the G2_Austin first cell production timeline slipping from year-end 2026 to Q1 2027, how does this impact the previously issued $375M - $450M integrated EBITDA run-rate target for 2027?